Oncolytics Biotech
ONCY
#9263
Rank
NZ$0.17 B
Marketcap
NZ$1.64
Share price
-4.78%
Change (1 day)
8.53%
Change (1 year)

Oncolytics Biotech (ONCY) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$1.03 Million

According to Oncolytics Biotech 's latest financial reports the company's total debt is NZ$1.03 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Oncolytics Biotech - Total debt on balance sheet (from 2000 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$1.31 M160.7%
2023-12-31NZ$0.5 M16.48%
2022-12-31NZ$0.43 M-42.46%
2021-12-31NZ$0.75 M72.18%
2020-12-31NZ$0.43 M-24.07%
2019-12-31NZ$0.57 M
2018-12-31N/A
2006-12-31NZ$0.18 M-2.99%
2005-12-31NZ$0.18 M7.7%
2004-12-31NZ$0.17 M-1.61%
2003-12-31NZ$0.17 M-1.98%
2002-12-31NZ$0.18 M-19.97%
2001-12-31NZ$0.22 M0.36%
2000-12-31NZ$0.22 M13.53%
1999-12-31NZ$0.19 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Aeterna Zentaris
AEZS
NZ$2.92 M 181.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$73.59 B 7,087,806.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$88.37 B 8,510,903.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$29.56 B 2,846,794.98%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
NZ$66.97 M 6,349.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
NZ$86.95 M 8,274.60%๐Ÿ‡บ๐Ÿ‡ธ USA